跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CARBIMAZOLE 5 TABLET 5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
CARBIMAZOLE 5 TABLET 5 MG
Approved
THERAPEUTIC
CARBIMAZOLE 5 TABLET 5 MG
REMEDICA LTD (CYPRUS)
🇸🇬 Health Sciences Authority
Approval Date
Mar 23, 1992
Approval ID
ccf963fba2b21b2f
Company
REMEDICA LTD (CYPRUS)
Type
Therapeutic
Approval Details
Approval Id
ccf963fba2b21b2f
Drug Name
CARBIMAZOLE 5 TABLET 5 MG
Product Name
CARBIMAZOLE 5 TABLET 5 MG
Approval Number
SIN06923P
Approval Date
1992-03-23
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
H03BB01
Atc Item Name
carbimazole
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Active Ingredients
CARBIMAZOLE
5 mg
CARBIMAZOLE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 23, 1992
Approval ID
ccf963fba2b21b2f
Type
Therapeutic
Back to HSA Approvals